Legacy Capital Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $853K | Buy |
4,597
+295
| +7% | +$54.8K | 0.19% | 105 |
|
|
2025
Q1 | $901K | Buy |
4,302
+152
| +4% | +$31.8K | 0.22% | 93 |
|
|
2024
Q4 | $737K | Sell |
4,150
-319
| -7% | -$56.7K | 0.18% | 111 |
|
|
2024
Q3 | $883K | Buy |
4,469
+371
| +9% | +$73.3K | 0.18% | 114 |
|
|
2024
Q2 | $703K | Buy |
+4,098
| New | +$703K | 0.18% | 113 |
|
|
2024
Q1 | – | Sell |
-3,447
| Closed | -$534K | – | 113 |
|
|
2023
Q4 | $534K | Buy |
3,447
+4
| +0.1% | +$620 | 0.15% | 136 |
|
|
2023
Q3 | $513K | Buy |
+3,443
| New | +$513K | 0.14% | 141 |
|
|
2023
Q2 | – | Sell |
-3,017
| Closed | -$481K | – | 42 |
|
|
2023
Q1 | $481K | Buy |
+3,017
| New | +$481K | 0.13% | 140 |
|
|
2021
Q2 | – | Sell |
-1,953
| Closed | -$211K | – | 25 |
|
|
2021
Q1 | $211K | Buy |
+1,953
| New | +$211K | 0.09% | 77 |
|